SIGN UP
LOG IN
J
JAZZ
Jazz Pharmaceuticals Plc
119.90
2.72+2.32%Opening13:32 05/02 EDT
OPEN/PREV CLOSE118.82/117.18
TODAY RANGE118.75-120.60
VOL381.60K
MARKET CAP7.39B
52 WEEK RANGE95.49-148.06
AVG VOL (3M)1.19M
% TURNOVER0.62%
TURNOVER--
P/E (TTM)13.86
% RANGE1.58%
EPS(TTM)8.65
P/E(FORWARD)12.23
P/B1.776
BVPS67.52
DIVIDEND--
P/S1.787
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.18B
SHARES OUTSTANDING61.63M
NEXT EARNINGS--
FREE FLOAT59.86M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Franklin Convertible Securities Fund Q1 2025 Commentary
NASDAQ·3d ago
3 Unconventional Cannabis Stocks to Watch in 2025
TipRanks·4d ago
Jazz Pharmaceuticals (JAZZ) Gets a Buy from RBC Capital
Simply Wall St·5d ago
Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Deserve A Spot On Your Watchlist?
Seeking Alpha·04/25 16:29
PTC and Jazz Pharmaceuticals among latest firms to win EU backing for drugs
TipRanks·04/25 15:30
Jazz Pharmaceuticals receives CHMP positive opinion for zanidatamab
NASDAQ·04/23 15:17
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
Barchart·04/23 08:52
3 Small-Cap Stocks in the Doghouse
NASDAQ·04/22 11:21
Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?
NASDAQ·04/21 13:22
Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.